In the liver cancer cell line HCCLM3, overexpression of HMGB1 and RAGE is observed, and inhibition of the HMGB1/RAGE axis reduces the expression of p50 and p65 in the NF-kB signaling pathway, thereby inhibiting the migration and invasion of HCCLM3 (111). Here, AGER is linked to liver cancer.